Corticosteroids Should Not Be Used for Acute Spinal Cord Injury
Corticosteroids, specifically methylprednisolone, are not recommended for acute spinal cord injury because they provide no meaningful neurological benefit and significantly increase the risk of infectious complications. 1, 2
Guideline Consensus Against Steroid Use
The most authoritative recent guidelines uniformly recommend against corticosteroid administration:
The 2020 French guidelines issue a GRADE 1 (strong) recommendation against early steroid administration to improve neurological prognosis after acute traumatic spinal cord injury. 1, 2
The 2013 Congress of Neurological Surgeons downgraded methylprednisolone evidence from Class I to Class III, noting that all primary outcomes in the NASCIS trials were negative and any reported benefits came from post-hoc subgroup analyses—essentially data mining after the fact. 1, 2
NACTN centers demonstrated this practice shift dramatically: in 2008-2009,70% of patients received steroids, but after the 2013 CNS/AANS guidelines, usage dropped to 3.9-16.9% by 2013-2018. 3
Why Steroids Fail: The Evidence
No Neurological Benefit
NASCIS I compared two methylprednisolone doses (1g vs 100mg) and found no difference in neurological improvement between groups, with no placebo control making efficacy conclusions impossible. 1, 2
NASCIS II reported only a modest motor score improvement at 6 months in patients treated within 8 hours, but this finding emerged from post-hoc subgroup analysis without pre-specified endpoints—not the primary outcome. 1, 2
NASCIS III compared 24-hour versus 48-hour infusions and found no additional motor improvement with longer treatment. 1
A large Canadian propensity-score matched cohort (approximately 1,600 controls, 46 treated) found no improvement in one-year motor function after adjusting for neurological level and baseline severity. 1, 2
Significant Harm Profile
Infectious complications consistently occur at higher rates in steroid-treated patients:
NASCIS II showed a 7% infection rate versus 3% in the placebo group. 1, 2
The Canadian cohort demonstrated a total complication rate of 61% versus 36% (p=0.02) in non-steroid patients. 2
Pulmonary complications occurred in 87% of steroid-treated patients versus 73% in those not receiving steroids (p=0.0003). 3
Urinary tract infections and pulmonary infections occur more frequently across multiple studies in patients receiving methylprednisolone. 1, 2, 4
What to Do Instead: Evidence-Based Interventions
Prioritize these proven interventions that actually improve outcomes:
Hemodynamic Management
Maintain mean arterial pressure >70 mmHg for the first 5-7 days post-injury using continuous arterial line monitoring; spinal cord perfusion pressure >50 mmHg correlates with better 6-month neurological status. 2, 4
Rigorously avoid hypotension (systolic BP <90 mmHg) throughout the acute phase, as secondary ischemic injury significantly worsens outcomes. 2, 4
Immediate Transfer
- Transfer immediately to a specialized spinal cord injury center (GRADE 2+ recommendation); this intervention reduces morbidity and long-term mortality compared with non-specialized care. 1, 2, 4
Early Imaging
- Obtain early MRI when neurological deficits are unexplained by CT, to identify medullary compression, contusion, ligament injury, disc herniation, or epidural hematoma that may require urgent surgical decompression. 1, 2, 4
Critical Pitfall to Avoid
Do not delay transfer to a specialized center or other proven interventions while considering methylprednisolone. The drug provides no neurological benefit and increases infection risk, whereas delayed transfer to specialized care is associated with worse outcomes. 2, 4
The One Exception (Weak and Controversial)
The 2017 AO Spine guidelines suggested offering a 24-hour infusion of high-dose methylprednisolone as a treatment option (not recommendation) to patients within 8 hours of acute SCI, based on the modest and questionable NASCIS II subgroup findings. 5, 3 However, this weak suggestion contradicts the stronger, more recent French GRADE 1 recommendation against use and the CNS downgrade of the evidence quality. 1, 2
Given the lack of meaningful benefit, increased infection risk, and availability of proven alternatives (hemodynamic support, specialized center transfer), steroids should not be used in acute spinal cord injury.